Dividend History


Forecast Next Dividend Date: Saturday 21 September 2019
Days remaining until next forecast dividend: 278
This is only a forecast. Forecast ex-dividend dates are taken from company's website or by using previous ex-dividend dates as a guide. Please confirm ex-dividend date with your broker.

Dividend Star Rating for CLINUVEL PHARMACEUTICALS(CUV)

Yield

Reliability

Dividend Growth

Relative Strength

Earnings Growth

Overall

Fundamental Data for CLINUVEL PHARMACEUTICALS(CUV)

Sector: Software & Services
Price: $0.00 (delayed)
Year High: $14.94
Year Low: $6.36
Market Capitalisation: $0.706 billion
Net Tangible Assets: $0.82 billion
Earnings per Share: 0.82 cents
Price Earnings Ratio: 53.3
Forecast Earnings Growth (5 years): 0% per annum
Dividend Cover: 13.85

Dividend Payment History for CLINUVEL PHARMACEUTICALS(CUV)

Ex-Dividend Date Books Close Date Date Payable Amount Franking Franking Credit Gross Dividend Cum Div Price Gross Yield RoI
21-09-201824-09-201808-10-2018$0.020%$0.00$0.02---

Notes:

  • Care should be taken interpreting this chart as all dividend payments for final year may not have been paid.
  • The financial year that the dividend is allocated depends on the payment date of the dividend, not the ex-dividend date.
  • Dividend history has not been adjusted for any capital reconstructions which may have effected dividend entitlement per share.

Dividend News Articles for CLINUVEL PHARMACEUTICALS(CUV)


3 Biotech/Healthcare Stocks – PAR, CUV And NUH - Kalkine Media
3 Biotech/Healthcare Stocks – PAR, CUV And NUH  Kalkine Media

The biotech and health care are one of the best sectors in the world. It also remains the biggest employer in the Australian economy and as technology takes ...



Why the Clinuvel Pharmaceuticals Limited (ASX:CUV) share price is rocketing today - Motley Fool Australia
Why the Clinuvel Pharmaceuticals Limited (ASX:CUV) share price is rocketing today  Motley Fool Australia

Shares in Clinuvel Pharmaceuticals Limited (ASX: CUV) surged 14% to $12.15 on Monday, as the company advanced its plans to launch its flagship product in ...



Clinuvel Pharmaceuticals Limited (ASX:CUV) shares have been smashed today - Motley Fool Australia
Clinuvel Pharmaceuticals Limited (ASX:CUV) shares have been smashed today  Motley Fool Australia

The Clinuvel Pharmaceuticals Limited (ASX:CUV) share price has been one of the worst performers on the market today. Here's what you need to know...



CLINUVEL delivers second positive financial result Australian Stock Exchange:CUV.AX - GlobeNewswire
CLINUVEL delivers second positive financial result Australian Stock Exchange:CUV.AX  GlobeNewswire

MELBOURNE, Australia, Aug. 29, 2018 (GLOBE NEWSWIRE) --. EXECUTIVE SUMMARY – FINANCIAL YEAR 01 JULY TO 30 JUNE. 2017/18, 2016/17 ...



The CSL Limited (ASX:CSL) share price is down 24% from its peak – is it time to buy? - Motley Fool Australia
The CSL Limited (ASX:CSL) share price is down 24% from its peak – is it time to buy?  Motley Fool Australia

The CSL Limited (ASX: CSL) share price is down 24% from its 52-week high of $232 per share and whilst the broader market has also suffered in recent weeks, ...



2 ASX listed biotech companies to get excited about - Motley Fool Australia
2 ASX listed biotech companies to get excited about  Motley Fool Australia

Biotechnology is defined as the genetic engineering of living organisms to provide commercial products, and if a cure for cancer is possible, this is likely the way ...



Is it too late to buy these market-beaters? - Motley Fool Australia
Is it too late to buy these market-beaters?  Motley Fool Australia

The market may have been struggling to push higher this month but that hasn't stopped some shares from putting on strong gains. Three shares that have ...



Why these 4 ASX shares are tumbling lower today - Motley Fool Australia
Why these 4 ASX shares are tumbling lower today  Motley Fool Australia

The Ramsay Health Care Limited (ASX:RHC) share price is one of four tumbling lower on Tuesday. Here's why...



6 Biotech Stocks on Fire in 2018 - TheBull.com.au
6 Biotech Stocks on Fire in 2018  TheBull.com.au

Healthcare stocks around the world are attracting heavy investor interest for many reasons, chief among them the expanding ageing population and longer life ...



5 under-the-radar shares for savvy Generation Y investors - Motley Fool Australia
5 under-the-radar shares for savvy Generation Y investors  Motley Fool Australia

5 stocks to help Generation Y come into its own as investors.



Disclaimer
The information provided on this website is for use of a general nature only and is not intended to be relied upon as, nor to be a substitute for, specific professional or investment advice. The team at Dividends.com.au are not lawyers, financial planners, investment advisers, or accountants. So, before taking any action or risking any money, you should always check with your own qualified professional advisers.